Using tranexamic acid for an additional 24 hours postoperatively in hip and knee arthroplasty saves money: a cost analysis from the TRAC-24 randomized control trial

Aims: Tranexamic acid (TXA) is now commonly used in major surgical operations including orthopaedics. The TRAC-24 randomized control trial (RCT) aimed to assess if an additional 24 hours of TXA postoperatively in primary total hip (THA) and total knee arthroplasty (TKA) reduced blood loss. Contrary...

Descripción completa

Detalles Bibliográficos

Autores principales:	Paul N. Karayiannis, Ashley Agus, Leanne Bryce, J. C. Hill, David Beverland
Formato:	Artigo
Lenguaje:	Inglês
Publicado:	The British Editorial Society of Bone & Joint Surgery 2022-07-01
Colección:	Bone & Joint Open
Materias:	cost analysis tranexamic acid hip arthroplasty knee arthroplasty randomized control trial hip and knee arthroplasty total knee arthroplasty (tka) hip blood loss blood transfusions primary total hip arthroplasty saves
Acceso en línea:	https://online.boneandjoint.org.uk/doi/epdf/10.1302/2633-1462.37.BJO-2021-0213.R1
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!